172 related articles for article (PubMed ID: 16509198)
1. [Cutaneous rash from the use of medicine for rheumatoid arthritis].
Hannuksela M
Duodecim; 2006; 122(1):105, 111. PubMed ID: 16509198
[No Abstract] [Full Text] [Related]
2. Pustular skin lesions in patients treated with infliximab: report of two cases.
Starmans-Kool MJ; Peeters HR; Houben HH
Rheumatol Int; 2005 Sep; 25(7):550-2. PubMed ID: 15711788
[TBL] [Abstract][Full Text] [Related]
3. Generalized pustulosis induced by adalimumab in a patient with rheumatoid arthritis - a therapeutic challenge.
Kucharekova M; Winnepenninckx V; Frank J; Poblete-Gutiérrez P
Int J Dermatol; 2008 Nov; 47 Suppl 1():25-8. PubMed ID: 18986481
[TBL] [Abstract][Full Text] [Related]
4. Severe polymyositis and flare in autoimmunity following treatment with adalimumab in a patient with overlapping features of polyarthritis and scleroderma.
Liozon E; Ouattara B; Loustaud-Ratti V; Vidal E
Scand J Rheumatol; 2007; 36(6):484-6. PubMed ID: 18092275
[No Abstract] [Full Text] [Related]
5. Pseudolymphomatoid cutaneous leishmaniasis in a patient treated with adalimumab for rheumatoid arthritis.
Baltà-Cruz S; Alsina-Glbert M; Mozos-Rocafort A; Cervera C; Colomo-Saperas L; Del Río A; Estrach-Panella T
Acta Derm Venereol; 2009; 89(4):432-3. PubMed ID: 19688168
[No Abstract] [Full Text] [Related]
6. Cutaneous vasculitis associated with infliximab in the treatment of rheumatoid arthritis.
Anandacoomarasamy A; Kannangara S; Barnsley L
Intern Med J; 2005 Oct; 35(10):638-40. PubMed ID: 16207269
[No Abstract] [Full Text] [Related]
7. Treatment, management, and monitoring of established rheumatoid arthritis.
Bingham CO; Miner MM
J Fam Pract; 2007 Oct; 56(10 Suppl Rapid):S1-7; quiz S8. PubMed ID: 17949607
[No Abstract] [Full Text] [Related]
8. [Cutaneous pseudolymphoma with two types of anti-TNFα: a class effect?].
Schmutz JL; Trechot P
Ann Dermatol Venereol; 2012 Oct; 139(10):695-6. PubMed ID: 23122389
[No Abstract] [Full Text] [Related]
9. Cutaneous drug eruption to infliximab: report of 4 cases with an interface dermatitis pattern.
Vergara G; Silvestre JF; Betlloch I; Vela P; Albares MP; Pascual JC
Arch Dermatol; 2002 Sep; 138(9):1258-9. PubMed ID: 12225003
[No Abstract] [Full Text] [Related]
10. Dermatomyositis during adalimumab therapy for rheumatoid arthritis.
Brunasso AM; Scocco GL; Massone C
J Rheumatol; 2010 Jul; 37(7):1549-50. PubMed ID: 20595297
[No Abstract] [Full Text] [Related]
11. [TNF-alpha inhibitors and demyelinating disease].
Böttiger Y
Lakartidningen; 2007 Nov 7-13; 104(45):3384. PubMed ID: 18062640
[No Abstract] [Full Text] [Related]
12. Acute generalized skin eruption due to adalimumab: report of two cases.
Dalmau J; Roé E; Corella F; García-Navarro X; Peramiquel L; Alomar A
J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1105-6. PubMed ID: 17714134
[No Abstract] [Full Text] [Related]
13. [Adalimumab in advanced and early rheumatoid arthritis].
Szekanecz Z
Orv Hetil; 2009 Jul; 150(28):1333-4. PubMed ID: 19581162
[No Abstract] [Full Text] [Related]
14. Dermatomyositis in patients with rheumatoid arthritis during adalimumab therapy.
Nagashima T; Minota S
J Rheumatol; 2011 Mar; 38(3):574; author reply 575. PubMed ID: 21362792
[No Abstract] [Full Text] [Related]
15. Infliximab-induced lupus erythematosus tumidus in a patient with rheumatoid arthritis.
Schneider SW; Staender S; Schlüter B; Luger TA; Bonsmann G
Arch Dermatol; 2006 Jan; 142(1):115-6. PubMed ID: 16415403
[No Abstract] [Full Text] [Related]
16. Tocilizumab-induced pustular drug eruption.
Mori T; Yamamoto T
Int J Rheum Dis; 2017 Nov; 20(11):1776-1777. PubMed ID: 26218136
[No Abstract] [Full Text] [Related]
17. Lack of adverse effect of anti-tumor necrosis factor-α biologics in treatment of rheumatoid arthritis: 5 years follow-up.
Dewedar AM; Shalaby MA; Al-Homaid S; Mahfouz AM; Shams OA; Fathy A
Int J Rheum Dis; 2012 Jun; 15(3):330-5. PubMed ID: 22709496
[TBL] [Abstract][Full Text] [Related]
18. Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial.
Burmester GR; Mariette X; Montecucco C; Monteagudo-Sáez I; Malaise M; Tzioufas AG; Bijlsma JW; Unnebrink K; Kary S; Kupper H
Ann Rheum Dis; 2007 Jun; 66(6):732-9. PubMed ID: 17329305
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor inhibitor therapy and risk of serious postoperative orthopedic infection in rheumatoid arthritis.
Giles JT; Bartlett SJ; Gelber AC; Nanda S; Fontaine K; Ruffing V; Bathon JM
Arthritis Rheum; 2006 Apr; 55(2):333-7. PubMed ID: 16583385
[No Abstract] [Full Text] [Related]
20. Cutaneous mucormycosis complicating methotrexate, prednisone, and infliximab therapy.
Gadadhar H; Hawkins S; Huffstutter JE; Panda M
J Clin Rheumatol; 2007 Dec; 13(6):361-2. PubMed ID: 18176152
[No Abstract] [Full Text] [Related]
[Next] [New Search]
